Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clarifying Frizzled 2 function in development through genetically validated mouse models.

Disease models & mechanisms·2026
Same author

Loss of ZNRF3/RNF43 unleashes EGFR in cancer.

eLife·2026
Same author

The class A repeats of LRP5 are required for normal development of bone, retinal vasculature and mammary gland in vivo.

Disease models & mechanisms·2025
Same author

Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs.

The Journal of clinical investigation·2024
Same author

Loss of ZNRF3/RNF43 Unleashes EGFR in Cancer.

bioRxiv : the preprint server for biology·2024
Same author

β-catenin-dependent High Bone Mass Induced by Loss of APC in Osteoblasts Does Not Require Lrp5 or Lrp6.

microPublication biology·2023
Same journal

Baseline β-CTX and BMI predict suitability for deferred zoledronic acid redosing beyond 12 months in postmenopausal Indian women with osteoporosis.

Bone·2026
Same journal

Bone density-based maturation of the midpalatal suture in children aged 8-15 years.

Bone·2026
Same journal

Disrupted phosphate metabolism and SIBLING/ASARM peptide accumulation underlie impaired bone mineralization in klotho-deficient (kl/kl) mice.

Bone·2026
Same journal

Linking genetic variants to bone microstructure: Histological signatures of osteogenesis imperfecta subtypes.

Bone·2026
Same journal

The impact of alcohol consumption on bone mineral density: Insights from cross-sectional and Mendelian randomization studies.

Bone·2026
Same journal

Systemic and local predictors of medication-related osteonecrosis of the jaw in patients receiving antiresorptive therapy: The Shizuoka Kokuho Database study.

Bone·2026
See all related articles

Related Experiment Video

Updated: Mar 5, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.7K

LRP5: From bedside to bench to bone.

Bart O Williams1

  • 1Center for Cancer and Cell Biology and Program for Skeletal Disease and Tumor Microenvironment, Van Andel Research Institute, United States.

Bone
|March 26, 2017
PubMed
Summary
This summary is machine-generated.

Genetic studies reveal that low-density lipoprotein-related receptor 5 (LRP5) and sclerostin (SOST) significantly impact human bone mass. Disruptions in these proteins lead to conditions of either low or high bone density.

Keywords:
Lrp5OsteoblastsSclerostinWntβ-Catenin

More Related Videos

Longitudinal Evaluation of Mouse Hind Limb Bone Loss After Spinal Cord Injury using Novel, in vivo, Methodology
10:39

Longitudinal Evaluation of Mouse Hind Limb Bone Loss After Spinal Cord Injury using Novel, in vivo, Methodology

Published on: December 7, 2011

15.6K
Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

88.6K

Related Experiment Videos

Last Updated: Mar 5, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.7K
Longitudinal Evaluation of Mouse Hind Limb Bone Loss After Spinal Cord Injury using Novel, in vivo, Methodology
10:39

Longitudinal Evaluation of Mouse Hind Limb Bone Loss After Spinal Cord Injury using Novel, in vivo, Methodology

Published on: December 7, 2011

15.6K
Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

88.6K

Area of Science:

  • Bone biology
  • Genetics
  • Endocrinology

Background:

  • Low-density lipoprotein-related receptor 5 (LRP5) genetic variations are linked to significant alterations in human bone mass.
  • Sclerostin (SOST) gene mutations also correlate with changes in bone density, highlighting its role in skeletal homeostasis.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of LRP5 and sclerostin in maintaining skeletal homeostasis.
  • To explore the interaction between sclerostin, LRP5, LRP6, and LRP4 in bone regulation.
  • To summarize findings from mouse models and clinical trials of SOST-blocking antibodies for increasing bone mass.

Main Methods:

  • Analysis of genetic alterations in LRP5 and SOST in human bone disorders.
  • Investigation of protein interactions using genetically engineered mouse models.
  • Review of clinical trial data for SOST-targeting therapies.

Main Results:

  • Loss of LRP5 function results in impaired osteoblast activity and reduced bone mass.
  • Loss of SOST function or LRP5 mutations preventing sclerostin binding lead to increased bone mass.
  • Sclerostin inhibits Wnt signaling by binding to LRP5/LRP6, a process facilitated by LRP4.

Conclusions:

  • LRP5 and sclerostin are critical regulators of bone mass, influencing osteoblast function and skeletal homeostasis.
  • Targeting the sclerostin-LRP5/6 interaction presents a therapeutic strategy for increasing bone mass, with clinical trials showing promise.